Update and validation of the Society for Vascular Surgery wound, ischemia, and foot infection threatened limb classification system

Seminars in Vascular Surgery

Volumn 27, Issue 1, 2014, Pages 16-22

  Mills, Joseph L ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRITICAL LIMB ISCHEMIA; DIABETES MELLITUS; DIABETIC FOOT; DISEASE CLASSIFICATION; DISEASE SEVERITY; FOOT DISEASE; FOOT INFECTION; GANGRENE; HUMAN; INFECTION; LEG REVASCULARIZATION; LIMB AMPUTATION; LIMB DISEASE; LIMB SALVAGE; NEUROPATHY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; REVIEW; THREATENED LIMB; WOUND CARE; WOUND HEALING; AMPUTATION; CLASSIFICATION; CRITICAL ILLNESS; DECISION SUPPORT SYSTEM; FOOT; ISCHEMIA; MEDICAL SOCIETY; NOMENCLATURE; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; REPRODUCIBILITY; RISK ASSESSMENT; RISK FACTOR; SEVERITY OF ILLNESS INDEX; VASCULARIZATION; WOUND INFECTION;

AMPUTATION; CRITICAL ILLNESS; DECISION SUPPORT TECHNIQUES; DIABETIC FOOT; FOOT; HUMANS; ISCHEMIA; LIMB SALVAGE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SOCIETIES, MEDICAL; TERMINOLOGY AS TOPIC; WOUND INFECTION;

EID: 84925150993     PISSN: 08957967     EISSN: 15584518     Source Type: Journal    
DOI: 10.1053/j.semvascsurg.2014.12.002     Document Type: Review

References (37)

1. Bell P.R.F., Charlesworth D., DePalma R.G., et al. The definition of critical ischaemia of a limb. Working Party of the International Vascular Symposium). Br J Surg 1982, 69(Suppl):S2.
2. Fontaine R., Kim M., Kieny R. Die chirugische Behandlung der peripheren Durchblutungstörungen. [Surgical treatment of peripheral circulation disorders]. Helv Chir Acta 1954, 21(5-6):499-533.
3. Rutherford R.B., Baker J.D., Ernst C., et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 1997, 26:517-538.
4. Norgren L., Hiatt W.R., Dormandy J.A., et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007, 45(Suppl S):S5-67.
5. Setacci C., Ricco J.B. Guidelines for critical limb ischemia and diabetic foot. Eur J Vasc Endovasc Surg 2011, 42(Suppl):S1-90.
6. Brass E.P., Anthony R., Dormandy J., et al. Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia. J Vasc Surg 2006, 43:752-759.
7. Marston W.A., Davies S.W., Armstrong B., et al. Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization. J Vasc Surg 2006, 44:108-114.
8. Elgzyri T., Larsson J., Thörne J., et al. Outcome of ischemic foot ulcer in diabetic patients who had no invasive vascular intervention. Eur J Vasc Endovasc Surg 2013, 46:110-117.
9. Mills J.L., Armstrong D.G., Andros G. Rescuing Sisyphus: the team approach to amputation prevention. J Vasc Surg 2010, 52(Suppl):1S-2S.
10. Skrepnek G.H., Armstrong D.G., Mills J.L. Open bypass and endovascular procedures among diabetic foot ulcer cases in the United States from 2001 to 2010. J Vasc Surg 2014, 60:1255-1265.
11. Hinchliffe R.J., Andros J., Apelqvist J., et al. A systematic review of the effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral arterial disease. Diabetes Metab Res Rev 2012, 28(Suppl 1):179-217.
12. Schaper N.C., Andros G., Apelqvist J., et al. Diagnosis and treatment of peripheral arterial disease in diabetic patients with a foot ulcer. A progress report of the International Working Group on the Diabetic Foot. Diabetes Metab Res Rev 2012, 28(Suppl 1):218-224.
13. Schaper N.C., Andros G., Apelqvist J., et al. Specific guidelines for the diagnosis and treatment of peripheral arterial disease in a patient with diabetes and ulceration of the foot. Diabetes Metab Res Rev 2012, 28(Suppl 1):236-237.
14. Armstrong D.G., Mills J.L. Toward a change in syntax in diabetic foot care. prevention equals remission. J Am Podiatr Med Assoc 2013, 103:161-162.
15. Armstrong D.G., Mills J.L. Juggling risk to reduce amputations: the three-ring circus of infection, ischemia and tissue loss dominant conditions. Wound Med 2013, 1:13-14.
16. Armstrong D.G., Cohen K., Courric S., et al. Diabetic foot ulcers and vascular insufficiency: our population has changed, but our methods have not. J Diabetes Sci Technol 2011, 52:1591-1595.
17. Ndip A., Jude E.B. Emerging evidence for neuroischemic diabetic foot ulcers: model of care and how to adapt practice. Int J Low Ext Wounds 2009, 8:82-94.
18. Prompers L., Huijberts M., Apelqvist J., et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia 2007, 50:18-25.
19. Armstrong D.G., Lavery L.A., Harkless L.B. Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care 1998, 21:855-859.
20. Lipsky B.A., Berendt A.R., Cornia P.B., et al. 2012 IDSA clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2012, 54:e132-e173.
21. Apelqvist J., Elgzyri T., Larrson J., et al. Factors related to outcome of neuroischemic/ischemic foot ulcer in diabetic patients. J Vasc Surg 2011, 53:1582-1588.
22. Prompers L., Schaper N., Apelqvist J., et al. Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study. Diabetologia 2008, 51:747-755.
23. Schaper N.C. Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies. Diabetes Metabol Res Rev 2004, 20(Suppl 1):S90-S95.
24. Taylor S.M., Kalbaugh C.A., Gray B.H., et al. The LEGS score: a proposed grading system to direct treatment of chronic lower extremity ischemia. Ann Surg 2003, 237:812-818. (discussion 818-9).
25. Goshima K.R., Mills J.L., Hughes J.D. A new look at outcomes following infrainguinal bypass surgery: traditional reporting standards systematically underestimate the expenditure of effort required to attain limb salvage. J Vasc Surg 2004, 39:330-335.
26. Mills J.L., Conte M.S., Armstrong D.G., et al. The Society for Vascular Surgery lower extremity threatened limb classification system: risk stratification based on wound, ischemia and foot infection (WIfI). J Vasc Surg 2014, 59:220-234.
27. Bradbury A.W., Adam D.J., Bell J., et al. Bypass versus Angioplasty in Severe Ischemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J Vasc Surg 2010, 51(Suppl):5S-17S.
28. Biancari F., Salenius J.P., Heikkinen M., et al. Risk-scoring method for prediction of 30-day postoperative outcome after infrainguinal surgical revascularization for critical lower-limb ischemia: a Finnvasc registry study. World J Surg 2007, 31:217-227.
29. Arvela E., Söderström M., Korhonen M., et al. Finnvasc score and modified Prevent III score predict long-term outcome after infrainguinal surgical and endovascular revascularization for critical limb ischemia. J Vasc Surg 2010, 52:1218-1225.
30. Schanzer A., Mega J., Meadows J., et al. Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data. J Vasc Surg 2008, 48:1464-1471.
31. Cull D.L., Manos G., Hartley M.C., et al. An early validation of the Society for Vascular Surgery lower extremity threatened limb classification system. J Vasc Surg 2014, 60:1535-1542.
32. Zhan LX, Branco BC, Armstrong DG, Mills JL. The Society for Vascular Surgery (SVS) lower extremity threatened limb classification system based on wound, ischemia, and foot infection (WIfI) correlates with risk of major amputation and time to wound healing. J Vasc Surg, April 15, http://dx.doi.org/10.1016/j.jvs2014.11.045.
33. Causey M.W., Wu B., Dini M., et al. Society for Vascular Surgery (SVS) lower extremity threatened limb classification discriminates early outcomes in hospitalized patients. J Vasc Surg 2014, 59(Suppl):103S-104SS.
34. Benoit E., O'Donnell T.F., Iafrati M.D., et al. The role of amputation as an outcome measure in cellular therapy for critical limb ischemia: implications for clinical trial design. J Transl Med 2011, 9:165.
35. Powell R.J. Update on clinical trials evaluating the effect of biologic therapy in patients with critical limb ischemia. J Vasc Surg 2012, 56:264-266.
36. Mills JL. Open bypass and endoluminal therapy: complementary techniques for revascularization in diabetic patients with critical limb ischemia. 5th International Symposium on the Diabetic Foot. Diabetes/Metabolism, Research and Reviews. Diabetes Metab Res Rev 2008;24(Suppl 1):S34-9.
37. Cronenwett J.L., Likosky D.S., Russell M.T., et al. A regional registry for quality assurance and improvement: the Vascular Study Group of Northern New England (VSGNNE). J Vasc Surg 2007, 46:1093-1101.